Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report

BACKGROUND: Dasatinib is a second-generation tyrosine kinase inhibitor that is indicated for the treatment of patients with chronic myeloid leukemia. Here, we report the case of a man with nephrotic syndrome that was caused by dasatinib. CASE PRESENTATION: A 40-year-old man with chronic myeloid leuk...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochiai, Shoko, Sato, Yuji, Minakawa, Akihiro, Fukuda, Akihiro, Fujimoto, Shouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407224/
https://www.ncbi.nlm.nih.gov/pubmed/30845905
http://dx.doi.org/10.1186/s12882-019-1273-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407224/
https://www.ncbi.nlm.nih.gov/pubmed/30845905
http://dx.doi.org/10.1186/s12882-019-1273-6

Ejemplares similares